Search research articles
Contact Us
Filters
Showing results (471-480 of 600) with videos related to
Page
of 60
Sort By:
The Journal of Rheumatology
|
March 17, 2010
Reproducibility of joint swelling assessment by sonography in patients with long-lasting rheumatoid arthritis (SEA-Repro study part II)
Sandrine Jousse-Joulin, Maria Antonietta d'Agostino, Thierry Marhadour, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 15, 2022
Characterization of Blood Mucosal-Associated Invariant T Cells in Patients With Axial Spondyloarthritis and of Resident Mucosal-Associated Invariant T Cells From the Axial Entheses of Non-Axial Spondyloarthritis Control Patients
Nicolas Rosine, Hannah Rowe, Surya Koturan, et al.
Annals of the Rheumatic Diseases
|
March 17, 2017
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis
Sofia Ramiro, Alexandre Sepriano, Katerina Chatzidionysiou, et al.
Joint Bone Spine
|
April 22, 2006
Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion
Laure Gossec, Stephan Pavy, Thao Pham, et al.
Arthritis and Rheumatism
|
September 2, 2006
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B Cohen, Paul Emery, Maria W Greenwald, et al.
Joint Bone Spine
|
April 22, 2006
Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion
Stephan Pavy, Arnaud Constantin, Thao Pham, et al.
Advances in Therapy
|
October 9, 2020
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis
Stanley B Cohen, Jeffrey D Greenberg, James Harnett, et al.
Annals of the Rheumatic Diseases
|
December 16, 2006
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis
Federico Díaz-González, Rieke H E Alten, William G Bensen, et al.
Annals of the Rheumatic Diseases
|
August 14, 2015
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
Walter P Maksymowych, Maxime Dougados, Désirée van der Heijde, et al.
Lancet (London, England)
|
October 27, 2018
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
Désirée van der Heijde, James Cheng-Chung Wei, Maxime Dougados, et al.
Page
of 60
Search research articles
Search
Showing results (471-480 of 600) with videos related to
Sort By:
Page
of 60
The Journal of Rheumatology
|
March 17, 2010
Reproducibility of joint swelling assessment by sonography in patients with long-lasting rheumatoid arthritis (SEA-Repro study part II)
Sandrine Jousse-Joulin, Maria Antonietta d'Agostino, Thierry Marhadour, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 15, 2022
Characterization of Blood Mucosal-Associated Invariant T Cells in Patients With Axial Spondyloarthritis and of Resident Mucosal-Associated Invariant T Cells From the Axial Entheses of Non-Axial Spondyloarthritis Control Patients
Nicolas Rosine, Hannah Rowe, Surya Koturan, et al.
Annals of the Rheumatic Diseases
|
March 17, 2017
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis
Sofia Ramiro, Alexandre Sepriano, Katerina Chatzidionysiou, et al.
Joint Bone Spine
|
April 22, 2006
Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion
Laure Gossec, Stephan Pavy, Thao Pham, et al.
Arthritis and Rheumatism
|
September 2, 2006
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B Cohen, Paul Emery, Maria W Greenwald, et al.
Joint Bone Spine
|
April 22, 2006
Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion
Stephan Pavy, Arnaud Constantin, Thao Pham, et al.
Advances in Therapy
|
October 9, 2020
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis
Stanley B Cohen, Jeffrey D Greenberg, James Harnett, et al.
Annals of the Rheumatic Diseases
|
December 16, 2006
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis
Federico Díaz-González, Rieke H E Alten, William G Bensen, et al.
Annals of the Rheumatic Diseases
|
August 14, 2015
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
Walter P Maksymowych, Maxime Dougados, Désirée van der Heijde, et al.
Lancet (London, England)
|
October 27, 2018
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
Désirée van der Heijde, James Cheng-Chung Wei, Maxime Dougados, et al.
Page
of 60